🟢 MDxHealth is trading 6.9% up in pre-market; catalyst remains unclear

MDxHealth is trading 6.9% higher at $0.62 in pre-market on October 2, 2026, with no clear company-specific catalyst identified.

• The move follows a 5.4% after-hours gain on October 1, also reported without a clear company-specific catalyst.
• Healthcare was down 1.32% pre-market, so the sector context does not explain MDxHealth’s rise. Company news listings showed earlier updates, not a new October 2 catalyst.